$0.40
+0.00 (+1.01%)
Open$0.40
Previous Close$0.40
Day High$0.40
Day Low$0.37
52W High$15.00
52W Low$0.23
Volume—
Avg Volume66.3K
Market Cap66.56M
P/E Ratio—
EPS$-0.17
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.46M | 45.50M | 43.44M |
| Net Income | 5.47M | 5.03M | 5.89M |
| Profit Margin | 12.3% | 11.1% | 13.6% |
| EBITDA | 8.24M | 9.46M | 8.95M |
| Free Cash Flow | 4.73M | 3.67M | 4.46M |
| Rev Growth | +4.4% | +9.5% | -0.1% |
| Debt/Equity | 0.49 | 0.48 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |